# Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections

> **NCT04751643** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 21 (actual)

## Conditions studied

- Intensive Care Units
- ARDS, Human
- Covid19

## Interventions

- **OTHER:** Therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3)
- **OTHER:** Usual treatments in intensive care unit according to the current state of knowledge

## Key facts

- **NCT ID:** NCT04751643
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2022-12-19
- **Final completion:** 2022-12-19
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04751643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04751643, "Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04751643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*